Who invested in Memento Medicines?
Memento Medicines's investors include RA Capital Management, Forbion Capital Partners, Samsara BioCapital and Sanofi.
United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$93Mraised across 1 round since 2026, from 1 source
Source recordedSEC filing: $38M sold
Memento Medicines's investors include RA Capital Management, Forbion Capital Partners, Samsara BioCapital and Sanofi.
Memento Medicines has raised $93M across 1 round since 2026.
Memento Medicines's most recent round was a Series A of $93M in Jun 2026.
Its most recent round, $93M in Jun 2026, is also its largest on record.
Memento Medicines's first round on record, in Jun 2026, was backed by RA Capital Management, Forbion Capital Partners and Samsara BioCapital and 1 others.
Memento Medicines's latest named round is a Series A, in Jun 2026.
Memento Medicines is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.